Evidence map›Paper›PMID 29371698›Full record

ArticleExperimental & molecular medicine2018

Rab25 augments cancer cell invasiveness through a β1 integrin/EGFR/VEGF-A/Snail signaling axis and expression of fascin.

Bo Young Jeong, Kyung Hwa Cho, Kang Jin Jeong, Yun-Yong Park, Jin Man Kim, Sun Young Rha, Chang Gyo Park, Gordon B Mills, Jae-Ho Cheong, Hoi Young Lee

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Experimental & molecular medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Explainable Deep Learning of Transcriptomes Prioritizes Candidate Biomarkers With Preferential Performance in Gastric Cardia Cancer Cohorts.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  3. Article
  4. Review
  5. Exploring the interactions of integrins and CEACAM6 (Review).Experimental and therapeutic medicine · 2025
    Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Endocytosis in cancer and cancer therapy.Nature reviews. Cancer · 2023
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Bo Young JeongDepartment of Pharmacology, College of Medicine, Konyang University, Daejeon, Korea.
Kyung Hwa ChoDepartment of Pharmacology, College of Medicine, Konyang University, Daejeon, Korea.
Kang Jin JeongDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Yun-Yong ParkDepartment of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Jin Man KimCancer Research Institute, Regional Cancer Center and Infection Signaling Network Research Center, Chungnam National University School of Medicine, Daejeon, Korea.
Sun Young RhaDivison of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
Chang Gyo ParkDepartment of Pharmacology, College of Medicine, Konyang University, Daejeon, Korea.
Gordon B MillsDepartment of Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Jae-Ho CheongDepartment of Surgery, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
Hoi Young LeeDepartment of Pharmacology, College of Medicine, Konyang University, Daejeon, Korea.
Konyang University · KRThe University of Texas MD Anderson Cancer Center · USChungnam National University · KRSeverance Hospital · KRUniversity of Ulsan · KRYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The small GTP-binding protein Rab25 is associated with tumor formation and progression. However, recent studies have shown discordant effects of Rab25 on cancer cell progression depending on cell lineage. In the present study, we elucidate the underlying mechanisms by which Rab25 induces cellular invasion. We demonstrate that Rab25 increases β1 integrin levels and subsequent activation of EGFR and upregulation of VEGF-A expression, leading to increased Snail expression, epithelial-to-mesenchymal transition and cancer cell invasiveness. Strikingly, we identify that Snail mediates Rab25-induced cancer cell invasiveness through fascin expression and that ectopic expression of Rab25 aggravates metastasis of ovarian cancer cells to the lung. We thus demonstrate a novel role of a β1 integrin/EGFR/VEGF-A/Snail signaling cascade in Rab25-induced cancer cell aggressiveness through induction of fascin expression, thus providing novel biomarkers and potential therapeutic targets for Rab25-expressing cancer cells.

Indexed as

AnimalsBreast NeoplasmsCarrier ProteinsCell Line, TumorErbB ReceptorsFemaleGene Expression Regulation, NeoplasticHumansIntegrin beta1Kaplan-Meier EstimateMice, NudeMicrofilament ProteinsOvarian Neoplasmsrab GTP-Binding ProteinsSignal TransductionSnail Family Transcription FactorsCarrier ProteinsEGFR protein, humanErbB ReceptorsfascinIntegrin beta1Microfilament ProteinsRab25 protein, humanrab GTP-Binding ProteinsSNAI1 protein, humanSnail Family Transcription FactorsVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-1VEGFA protein, human

Identifiers

PMID29371698
PMCPMC5799805
OpenAlexW2784984702

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.